American Banking and Market News logo

The Latest Headlines at American Banking and Market News

Image about Aptose Biosciences (NASDAQ:APTO) Downgraded by StockNews.com to Sell

Aptose Biosciences (NASDAQ:APTO) Downgraded by StockNews.com to Sell

StockNews.com downgraded shares of Aptose Biosciences (NASDAQ:APTO – Free Report) (TSE:APS) from a hold rating to a sell rating in a research note released on Monday. Separately, Piper Sandler dropped their price target on Aptose... More of this article »
Image about Cyclacel Pharmaceuticals (NASDAQ:CYCC) Lowered to Sell at StockNews.com

Cyclacel Pharmaceuticals (NASDAQ:CYCC) Lowered to Sell at StockNews.com

StockNews.com cut shares of Cyclacel Pharmaceuticals (NASDAQ:CYCC – Free Report) from a hold rating to a sell rating in a research note released on Monday morning. A number of other equities analysts also recently issued reports... More of this article »
Image about Popular (NASDAQ:BPOP) Upgraded by StockNews.com to Hold

Popular (NASDAQ:BPOP) Upgraded by StockNews.com to Hold

StockNews.com upgraded shares of Popular (NASDAQ:BPOP – Free Report) from a sell rating to a hold rating in a research report report published on Monday. Several other brokerages also recently issued reports on BPOP. Barclays... More of this article »
Image about Akebia Therapeutics (NASDAQ:AKBA) Upgraded to “Buy” at StockNews.com

Akebia Therapeutics (NASDAQ:AKBA) Upgraded to “Buy” at StockNews.com

StockNews.com upgraded shares of Akebia Therapeutics (NASDAQ:AKBA – Free Report) from a hold rating to a buy rating in a report published on Monday. A number of other research firms also recently commented on AKBA. HC Wainwright... More of this article »
Image about Hilton Worldwide (NYSE:HLT) Price Target Increased to $210.00 by Analysts at Robert W. Baird

Hilton Worldwide (NYSE:HLT) Price Target Increased to $210.00 by Analysts at Robert W. Baird

Hilton Worldwide (NYSE:HLT – Free Report) had its target price raised by Robert W. Baird from $203.00 to $210.00 in a report published on Friday morning, Benzinga reports. Robert W. Baird currently has an outperform rating on... More of this article »
Image about Benchmark Lowers Hello Group (NASDAQ:MOMO) Price Target to $16.00

Benchmark Lowers Hello Group (NASDAQ:MOMO) Price Target to $16.00

Hello Group (NASDAQ:MOMO – Free Report) had its price objective trimmed by Benchmark from $22.00 to $16.00 in a research note published on Friday morning, Benzinga reports. The brokerage currently has a buy rating on the information... More of this article »
Image about Acacia Research (NASDAQ:ACTG) Upgraded to Hold by StockNews.com

Acacia Research (NASDAQ:ACTG) Upgraded to Hold by StockNews.com

StockNews.com upgraded shares of Acacia Research (NASDAQ:ACTG – Free Report) from a sell rating to a hold rating in a report issued on Monday. Several other equities analysts have also commented on the stock. TheStreet raised... More of this article »
Image about Atossa Therapeutics (NASDAQ:ATOS) Downgraded by StockNews.com to Sell

Atossa Therapeutics (NASDAQ:ATOS) Downgraded by StockNews.com to Sell

StockNews.com downgraded shares of Atossa Therapeutics (NASDAQ:ATOS – Free Report) from a hold rating to a sell rating in a research note released on Monday morning. Several other brokerages have also recently commented on ATOS.... More of this article »
Image about Pactiv Evergreen (PTVE) – Research Analysts’ Weekly Ratings Updates

Pactiv Evergreen (PTVE) – Research Analysts’ Weekly Ratings Updates

Several analysts have recently updated their ratings and price targets for Pactiv Evergreen (NASDAQ: PTVE): 3/4/2024 – Pactiv Evergreen had its “outperform” rating reaffirmed by analysts at Royal Bank of Canada.... More of this article »
Image about Galectin Therapeutics (NASDAQ:GALT) Lowered to Sell at StockNews.com

Galectin Therapeutics (NASDAQ:GALT) Lowered to Sell at StockNews.com

StockNews.com downgraded shares of Galectin Therapeutics (NASDAQ:GALT – Free Report) from a hold rating to a sell rating in a research note published on Monday. Galectin Therapeutics Stock Up 3.9 % GALT opened at $2.14 on Monday.... More of this article »
Image about Atara Biotherapeutics (NASDAQ:ATRA) Lowered to “Sell” at StockNews.com

Atara Biotherapeutics (NASDAQ:ATRA) Lowered to “Sell” at StockNews.com

StockNews.com lowered shares of Atara Biotherapeutics (NASDAQ:ATRA – Free Report) from a hold rating to a sell rating in a report published on Monday. Atara Biotherapeutics Stock Performance NASDAQ:ATRA opened at $0.60 on Monday.... More of this article »
Image about Wells Fargo & Company Increases Iron Mountain (NYSE:IRM) Price Target to $90.00

Wells Fargo & Company Increases Iron Mountain (NYSE:IRM) Price Target to $90.00

Iron Mountain (NYSE:IRM – Free Report) had its price objective upped by Wells Fargo & Company from $80.00 to $90.00 in a research report released on Friday morning, Benzinga reports. Wells Fargo & Company currently... More of this article »
Image about Air Transport Services Group (NASDAQ:ATSG) Upgraded to “Hold” by StockNews.com

Air Transport Services Group (NASDAQ:ATSG) Upgraded to “Hold” by StockNews.com

StockNews.com upgraded shares of Air Transport Services Group (NASDAQ:ATSG – Free Report) from a sell rating to a hold rating in a research report report published on Monday. A number of other brokerages have also issued reports... More of this article »
Image about Gilead Sciences (NASDAQ:GILD) Downgraded to Buy at StockNews.com

Gilead Sciences (NASDAQ:GILD) Downgraded to Buy at StockNews.com

StockNews.com cut shares of Gilead Sciences (NASDAQ:GILD – Free Report) from a strong-buy rating to a buy rating in a report released on Monday. A number of other equities analysts have also commented on GILD. Cantor Fitzgerald... More of this article »
Image about Grupo Financiero Galicia (NASDAQ:GGAL) Upgraded to “Buy” at StockNews.com

Grupo Financiero Galicia (NASDAQ:GGAL) Upgraded to “Buy” at StockNews.com

StockNews.com upgraded shares of Grupo Financiero Galicia (NASDAQ:GGAL – Free Report) from a hold rating to a buy rating in a research report released on Monday. Grupo Financiero Galicia Trading Up 3.9 % Shares of GGAL stock... More of this article »